There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
To describe the clinical effect and safety of low-dose buprenorphine, a κ-opioid receptor
antagonist, for treatment-resistant depression (TRD) in midlife and older adults.